Literature DB >> 11115238

Altered mental status in patients with cancer.

R Tuma1, L M DeAngelis.   

Abstract

OBJECTIVE: To identify the causes of an altered mental status in a cancer population.
METHODS: We studied 140 confused patients with cancer (100 prospectively and 40 retrospectively) between January 1, 1991, and June 30, 1992, to determine clinical findings, causes, and outcome.
RESULTS: All patients had non-central nervous system cancers. The most common primary cancer types were lung (20%), gastrointestinal tract (18%), leukemia and lymphoma (17%), and breast (11%). Median patient age was 73 years, and 49% were men. Disseminated systemic metastases were present in 50% of patients; 34% were confused at hospital admission and 66% developed confusion during hospitalization. Symptoms included lethargy or coma in 61% of patients, agitation in 44%, disorientation in 83%, lateralizing signs in 41%, delusions or hallucinations in 28%, and seizures in 9%. A single cause of the altered mental status was found in 33% of patients, whereas 67% had multiple causes. Drugs, especially opioids, were associated with altered mental status in 64% of patients, metabolic abnormalities in 53%, infection in 46%, and recent surgery in 32%. A structural brain lesion was the sole cause of encephalopathy in 15% of patients. Although delirium improved in 67% of patients, it was a poor prognostic factor for overall outcome. Thirty-day mortality was 25%, and 44% of patients died within 6 months, usually from progression of the underlying cancer. Prolonged delirium suggested infection or coagulopathy. Younger patients and those with hypoxemia or kidney or liver dysfunction were more likely to die (P<.05).
CONCLUSION: Patients with cancer usually have multiple causes of delirium, many of which are treatable, with rapid improvement in their cognitive status.

Entities:  

Mesh:

Year:  2000        PMID: 11115238     DOI: 10.1001/archneur.57.12.1727

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  18 in total

1.  Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial.

Authors:  Eduardo Bruera; David Hui; Shalini Dalal; Isabel Torres-Vigil; Joseph Trumble; Joseph Roosth; Susan Krauter; Carol Strickland; Kenneth Unger; J Lynn Palmer; Julio Allo; Susan Frisbee-Hume; Kenneth Tarleton
Journal:  J Clin Oncol       Date:  2012-11-19       Impact factor: 44.544

2.  Pre- and post-transplantation risk factors for delirium onset and severity in patients undergoing hematopoietic stem-cell transplantation.

Authors:  Jesse R Fann; Rebecca A Hubbard; Catherine M Alfano; Sari Roth-Roemer; Wayne J Katon; Karen L Syrjala
Journal:  J Clin Oncol       Date:  2011-01-24       Impact factor: 44.544

3.  Delirium in patients with head and neck cancer in the outpatient treatment setting.

Authors:  Stewart M Bond; Mary S Dietrich; John L Shuster; Barbara A Murphy
Journal:  Support Care Cancer       Date:  2011-05-05       Impact factor: 3.603

Review 4.  Central nervous system toxicity from cancer treatment.

Authors:  Terri Armstrong; Mark R Gilbert
Journal:  Curr Oncol Rep       Date:  2004-01       Impact factor: 5.075

Review 5.  Review of topiramate for the treatment of epilepsy in elderly patients.

Authors:  B R Sommer; H H Fenn
Journal:  Clin Interv Aging       Date:  2010-04-26       Impact factor: 4.458

Review 6.  The confused oncologic patient: a rational clinical approach.

Authors:  Craig Nolan; Lisa M DeAngelis
Journal:  Curr Opin Neurol       Date:  2016-12       Impact factor: 5.710

7.  An analytical framework for delirium research in palliative care settings: integrated epidemiologic, clinician-researcher, and knowledge user perspectives.

Authors:  Peter G Lawlor; Daniel H J Davis; Mohammed Ansari; Annmarie Hosie; Salmaan Kanji; Franco Momoli; Shirley H Bush; Sharon Watanabe; David C Currow; Bruno Gagnon; Meera Agar; Eduardo Bruera; David J Meagher; Sophia E J A de Rooij; Dimitrios Adamis; Augusto Caraceni; Katie Marchington; David J Stewart
Journal:  J Pain Symptom Manage       Date:  2014-04-12       Impact factor: 3.612

8.  Spectrum of nonconvulsive status epilepticus in patients with cancer.

Authors:  Meredith Spindler; Lindsay M Jacks; Xi Chen; Katherine Panageas; Lisa M DeAngelis; Edward K Avila
Journal:  J Clin Neurophysiol       Date:  2013-08       Impact factor: 2.177

Review 9.  Antibody-Mediated Autoimmune Diseases of the CNS: Challenges and Approaches to Diagnosis and Management.

Authors:  Elia Sechi; Eoin P Flanagan
Journal:  Front Neurol       Date:  2021-07-07       Impact factor: 4.003

10.  A randomized double-blind placebo-controlled trial of intravenous thiamine for prevention of delirium following allogeneic hematopoietic stem cell transplantation.

Authors:  Zev M Nakamura; Allison M Deal; Eliza M Park; Laura J Quillen; Stephanie A Chien; Kate E Stanton; Sean D McCabe; Hillary M Heiling; William A Wood; Thomas C Shea; Donald L Rosenstein
Journal:  J Psychosom Res       Date:  2021-04-27       Impact factor: 4.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.